RSV Surveillance And Cost-Effectiveness Data Presented By MedImmune

MedImmune, Inc. presented three abstracts at the American Academy of Pediatrics (AAP) 2007 National Conference & Exhibition, adding to the company’s growing body of research into the prevention of respiratory syncytial virus (RSV), a leading cause of hospitalization among infants.”MedImmune presented data that provide key insights into how we can optimize the fight against RSV,” said Jessie R. Groothuis, M.D., vice president, medical and scientific affairs, infectious disease. [click link for full article]

More: continued here

Filed under: Pediatrics on October 30th, 2007